Lv15
48 积分 2023-03-30 加入
Core Modifications of GSK3335103 toward Orally Bioavailable αvβ6 Inhibitors with Improved Synthetic Tractability
1小时前
待确认
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948
1天前
已完结
Self‐Assembled Antibody‐Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides
2天前
已完结
A Guide to Chemical Considerations for the Pre-Clinical Development of Oligonucleotides
7天前
已完结
Overcoming the challenges of tissue delivery for oligonucleotide therapeutics
10天前
已完结
Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination
10天前
已完结
Thermodynamics and Kinetics‐Directed Regulation of Nucleic Acid‐Based Molecular Recognition
10天前
已完结
Unlocking the Potential of Chemically Modified Nucleic Acid Therapeutics
11天前
已完结
An Accurate and Fast 31P qNMR Assay Method for Oligonucleotide Therapeutics
11天前
已完结
Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability
15天前
已完结
皖公网安备34019202002308
